Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. Signal., 1 July 2008 PERSPECTIVESp53 Brings a New Twist to the Smad Signaling NetworkAzeddine Atfi1,2* and Roland Baron2
1INSERM U893, Hôpital St-Antoine, 184 Rue du Faubourg St-Antoine, 75571 Paris, France. Abstract: Transforming growth factor beta (TGF-β) signaling regulates a plethora of cellular responses, including specification of developmental fate during embryogenesis, cell proliferation, differentiation, and apoptosis. Components of this pathway are often mutated in cancers and other human disorders. TGF-β signaling involves activation of transcriptional regulators of the Smad family. The tumor suppressor p53 is an essential partner of Smads, affecting TGF-β signaling at various points in the pathway. Inactivation of p53 may contribute to the aberrant behavior of cancer cells that escape the cytostatic action of TGF-β despite the apparent integrity of the TGF-β receptor or Smads. Thus, the discovery that p53 and TGF-β cooperate in cell-fate decisions and cellular homeostatic mechanisms has important pathophysiological implications. *Corresponding author. E-mail: azeddine.atfi{at}inserm.fr
Citation: A. Atfi, R. Baron, p53 Brings a New Twist to the Smad Signaling Network. Sci. Signal. 1, pe33 (2008). The editors suggest the following Related Resources on Science sites:In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882